References
- Fitzgerald G A, Pedersen A K, Patrono C. Analysis of Prostacyclin and Thromboxane Biosynthesis in Cardiovascular Disease. Circulation 1983; 67: 1174–1177
- Oates J A, Fitzgerald G A, Branch R A, Jackson E K, Knapp H R, Roberts L J. Clinical implications of prostaglandin and thromboxane A2 formation. N Engl J Med 1988; 319: 689–698
- Davies M J, Thomas A. Thrombosis and acute coronaryartery lesions in sudden cardiac ischemic death. N Engl J Med 1984; 310: 1137–1140
- DeWood M A, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980; 303: 897–902
- Ambrose J A, Hjemdahl-Monsen C E, Borrico S, Gorlin R, Fuster V. Angiographic Demonstration of a Common Link Between Unstable Angina Pectoris and Non-Q Wave Acute Myocardial Infarction. Am J Cardiol 1988; 61: 244–247
- Sherman C T, Litvack F, Grundfest W, et al. Coronary angioscopy in patients with unstable angina pectoris. N Engl J Med 1986; 315: 913–919
- Fitzgerald D J, Ray L, Catella F, Fitzgerald G A. Platelet activation in unstable coronary disease. N Engl J Med 1986; 315: 983–989
- Szczeklik A, Gryglewski RJ, Musial J, Grodzinska L, Serwonska M, Marcinkiewicz E. Thromboxane Generation and Platelet Aggregation in Survivals of Myocardial Infarction. Thromb Haemostas 1978; 40: 66–74
- Mikhailidis D P, Barradas M A, Mier A., et al. Platelet Function in Patients Admitted with a Diagnosis of Myocardial Infarction. Angiology 1987; 38: 36–45
- Patrono C. Aspirin for the prevention of coronary thrombosis: Current facts and perspectives. Eur Heart J 1980; 7: 454–459
- Lewis H D, David J W, Archibald D G, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med 1983; 309: 396–403
- Cairns J A, Gent M, Singer J, et al. Aspirin, sulfinpyrazone, or both in unstable angina. N Engl J Med 1985; 313: 1369–1375
- Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; ii: 349–360
- Knudsen J B, Gormsen J, Skagen K, Amtorp O. Changes in platelet functions, coagulation and fibrinolysis in incomplicated cases of acute myocardial infarction. Thromb Haemostas 1979; 42: 1513–1522
- Tansey M J B, Opie L H. Relation between plasma free fatty acids and arrhythmias within the first twelve hours of acute myocardial infarction. Lancet 1983; ii: 419–422
- Carter A J, Hanley S P. The effect of platelet number and haematocrit on whole blood thromboxane synthesis. Thromb Haemostas 1985; 53: 225–227
- Glud T, Schmidt E B, Kristensen S D, Arnfred T. Platelet number and volume during myocardial infarction in relation to infarct size. Acta Med Scand 1986; 220: 401–405
- Szczeklik A, Serwonska M, Lukasiewicz W, Mruk J, Musial J. Arachidonate versus ADP-induced platelet aggregation in acute myocardial infarction. Thromb Haemostas 1979; 42: 822–823
- Henriksson P, Wennmalm Å, Edhag O, Vestergvist O, Green K. In vivo production of prostacyclin and thomboxane in patients with acute myocardial infarction. Br Heart J 1986; 55: 543–548
- Gorlin R, Fuster V, Ambrose J A. Anatomic-physiologic links between acute coronary syndromes. Circulation 1986; 74: 6–9
- Feldman R L. Coronary Thrombosis, Coronary Spasm and Coronary Atherosclerosis and Speculation on the Link between Unstable Angina and Acute Myocardial Infarction. Am J Cardiol 1987; 59: 1187–1190